Provexis PLC operates in the Medicinals and botanicals sector. Provexis plc is a life sciences-driven company that discovers, develops and licenses technologies for the global functional food, medical food and dietary supplement sectors. The Company's technologies include Fruitflow, NSP#3G, isothiocyanate and blood glucose. Fruitflow is a heart-health technology. Fruitflow is a tomato extract, which inhibits platelet aggregation, a known cause of heart attack, stroke and venous thrombosis. NSP#3G is a technology for Crohn's disease. On June 1, 2010, it entered into an alliance with DSM Nutritional Products (DSM) to develop Fruitflow. The Company has 75% interest in a joint venture with the University of Liverpool, which owns the NSP#3G plantain extract for the treatment of inflammatory bowel disease. DSM launched Fruitflow to the industry in Europe in November 2010 and in the United States in March 2011. On June 17, 2011, the Company acquired SiS (Science in Sport) Limited (SiS), which manufactures and sells sports nutrition products. In our complete report available for purchase the company is compared to: Attitude Drinks Incorporation, Uplift Nutrition, Incorporation and Bio-Solutions Corporation.